Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
It is very uncertain whether levonorgestrel‐releasing intrauterine system (LNG‐IUS) changes regression rate at 6 months compared with medroxyprogesterone (MPA) 10 mg (very low certainty).
It is very uncertain whether levonorgestrel‐releasing intrauterine system (LNG‐IUS) changes nausea over 6‐month compared with medroxyprogesterone (MPA) 10 mg (very low certainty).
Levonorgestrel‐releasing intrauterine system (LNG‐IUS) may leads to higher vaginal bleeding over 6‐month compared with medroxyprogesterone (MPA) 10 mg (low certainty).
Direct measurement using calibrated drapes leads to higher blood loss ≥ 500 mL compared with indirect estimation using gravimetric technique (high certainty).
Direct measurement using calibrated drapes showed no clear difference in blood transfusion compared with indirect estimation using gravimetric technique (low certainty).
Direct measurement using calibrated drapes showed no clear difference in use of plasma expanders compared with indirect estimation using gravimetric technique (low certainty).
Direct measurement using calibrated drapes showed no clear difference in use of therapeutic uterotonics compared with indirect estimation using gravimetric technique (high certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether breast surgery plus systemic treatment changes overall survival at 2 years compared with systemic treatment (very low certainty).
The review found no eligible studies for this question.
Breast surgery plus systemic treatment may leads to lower local PFS at 2 years compared with systemic treatment (low certainty).
Breast surgery plus systemic treatment probably leads to higher distant PFS at 2 years compared with systemic treatment (moderate certainty).
The review found no eligible studies for this question.
Breast surgery plus systemic treatment showed no clear difference in toxicity from local therapy compared with systemic treatment (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether surgery plus whole brain radiotherapy (WBRT) changes overall survival compared with stereotactic radiosurgery (very low certainty).